Global Statistics Representing Chemotherapy Market Scenario
Chemotherapy is a type of cancer treatment which consists of the use of one or more chemotherapeutic agents including anti-cancer drugs. The treatment mainly prevents the cancer cells division and growth of cancer cells by killing the dividing cells. Moreover, it is used in the treatment of different types of cancer such as lung cancer, breast cancer, leukemia, myeloma, sarcoma, lymphoma, ovarian cancer, and others. Chemotherapy drugs can be injected directly into the bloodstream or can be targeted to exact cancer sites. However, this treatment has several side effects such as nausea & vomiting, alopecia, hair loss, fatigue, hearing impairment, mucositis, loss of appetite, and many more.
Moreover, technological advancement and rising emphasis on research and development in the field of oncology may propel the growth of the market.
Global chemotherapy market was valued at around USD 65,300 million in 2017 and is expected to grow with the CAGR of 7.2 % during forecast period.
Geographically, the chemotherapy market is categorized by drugs, indication, route of drug administration, and end-user.
Based on the drugs, the market is segmented into alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, and others. Alkylating agents is expected to dominate the market as it proliferates faster and with less error-correcting than healthy cells.
Based on the indication, the market is segmented into leukemia, lymphoma, breast cancer, ovarian cancer, lung cancer, myeloma, sarcoma, and others. Leukemia is expected to hold the major share owing to growing prevalence of leukemia across the globe.
On the basis of route of drug administration, the market is segmented into intravenous and oral. Oral segment is expected to dominate during forecast period.
Based on end-user, the market is segmented into hospitals, research institutes, and others.
Geographically, the market is split into four major regions such as North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).
North American market is mainly driven by presence of various players manufacturing chemotherapy drugs and growing healthcare expenditure. Additionally, available healthcare facilities and use of advance technologies in cancer research and treat also driving the market. Increasing uses of chemotherapy instead of other treatment owing to its property to destroy cancer cells is driving growth of the market. Increasing prevalence of cancer in U. S. is propelling the growth of the market. For instance, according to Centers for Disease Control and Prevention (CDC), around 650,000 cancer patients receive chemotherapy each year in United State.
Europe is expected to exhibit significant growth during forecast period. This is attributed to rising government support for research and development in chemotherapy market. Growing number of cancer patient in the region is supporting the growth of the market.
Asia pacific is expected to be the fastest growing region due to the growing demand for chemotherapy drugs and accessibility of well-qualified and capable healthcare professionals. Government reimbursement policies for cancer in India are propelling the growth of the market in the future.
The market is also growing in Middle East & Africa due to growing awareness about various types of cancer, their diagnosis, and available treatment options.
The global chemotherapy market comprises of various major players including Sanofi, Novartis, Pfizer Inc., Eli Lilly & Company, ImClone Systems Inc., GlaxoSmithKline, AstraZeneca, Schering-Plough, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceuticals Industries, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Chemo Espana SL, CELGENE CORPORATION, Amgen Inc, Bayer AG, Takeda Pharmaceutical Company Limited, and others.
Chemotherapy Market Segmentation
- Alkylating Agents
- Mustard Gas Derivatives
- Alkyl Sulfonates
- Anti-Tumor Antibiotics
- Topoisomerase Inhibitors
- Topoisomerase I Inhibitors
- Topoisomerase Ii Inhibitors
- Mitotic Inhibitors
- Breast Cancer
- Ovarian Cancer
- Lung Cancer
By Route of Drug Administration
- Research Institutes
- North America
Why buy this report right now?
Our report covers chemotherapy market insights, focusing on recent development in the market in different region and development strategies of the companies. Moreover, following sections are specifically covered in the report.
• Definitive Market Data
• cancer treatment market Analysis
• Competitive Analysis
• Recent Opportunities in the Market
• 6-7 year performance forecasts: major segments covering product type, cancer type, profiling technology, and application.
• Market Share Analysis
• Potential Venture Avenues